← Browse by Condition
Medical Condition
chronic pancreatitis
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, EARLY_Phase 1
ClinicalMetric tracks all active clinical trials for chronic pancreatitis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — chronic pancreatitis Clinical Trials
How many clinical trials are currently recruiting for chronic pancreatitis?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for chronic pancreatitis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chronic pancreatitis?
chronic pancreatitis research spans Phase 1 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chronic pancreatitis clinical trial?
Eligibility criteria for chronic pancreatitis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Top Sponsors
3 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05925036 Phase 1
Recruiting
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Enrollment
40 pts
Location
United States
Sponsor
VA Office of Research and Deve...
NCT06925204
Recruiting
Natural Course and Therapeutic Effect of Chronic Pancreatitis
Enrollment
5,000 pts
Location
China
Sponsor
Changhai Hospital
NCT04743479
Recruiting
Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)
Enrollment
5,000 pts
Location
China
Sponsor
Changhai Hospital
NCT04813055
Recruiting
Prospective Registry Of Therapeutic EndoscopiC ulTrasound
Enrollment
510 pts
Location
Italy
Sponsor
Paolo Giorgio Arcidiacono, MD
NCT05664880 EARLY_Phase 1
Recruiting
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
Enrollment
24 pts
Location
United States
Sponsor
Cedars-Sinai Medical Center
NCT06917716
Recruiting
Translation and Validation of Chinese COMPAT-SF
Enrollment
356 pts
Location
China
Sponsor
Changhai Hospital
NCT07174609
Recruiting
Scrambler Therapy in Chronic Pancreatitis
Enrollment
40 pts
Location
United States
Sponsor
Johns Hopkins University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology